"We failed to control the medical opioids and prevent them from causing harm," he said. "If somebody could present as having PTSD even if they didn't, and obtain a long-term take-home dose [of psychedelics] they could sell on the illegal market, that's a diversion problem."
Once taboo, psychedelic drugs offer vets new PTSD treatment option
→
This notion has an economic logic because “the greater the sanction risk, the more valuable it is to make things compact, which ought to favor potency,” said Jonathan Caulkins, a professor of operations research and public policy at Carnegie Mellon University.
Psychosis, suicidal thoughts, scream-vomiting: Alarm sounded about potent marijuana, THC products
→
